Nanoparticle albumin-bound paclitaxel - first step of nanotechnology into clinical practice

• Principais autores: R. N. Alyautdin (Autor), B. K. Romanov (Autor), В. К. Лепахин (Autor), N. D. Bunyatyan (Autor), V. A. Merkulov (Autor), A. N. Mironov (Autor)
• Formato: Livro
• Publicado em: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Paclitaxel is an effective antitumor agent used for treatment of breast cancer, lung, stomach and pancreas. However, its own adverse effects and the use of toxic Cremophor EL as the solvent limit the application range of this drug. Associated with the albumin-bound nanoparticle paclitaxel (paclitaxe...